First Progression of MGMT Promoter-methylated Glioblastoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which First Progression of MGMT Promoter-methylated Glioblastoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

WithdrawnPhase 2

NCT04933942

Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Gliob…

Romiplostim for low platelets caused by lomustine chemotherapy in patients with first recurrence (growing back) of a brain tumor, glioblastoma that is MGMT meth…

Spain, Switzerland0Started 2022-09-13

Treatment: Lomustine, Romiplostim